Details

Kakovost v edukativno-izobraževalnem procesu (audit kultura) : diplomsko delo
ID Trnavčević, Ana (Author), ID Židan, Alojzija (Mentor) More about this mentor... This link opens in a new window

URLURL - Presentation file, Visit http://dk.fdv.uni-lj.si/diplomska/pdfs/Trnavcevic-Ana.PDF This link opens in a new window

Language:Slovenian
Keywords:gimnazije
Work type:Undergraduate thesis
Typology:2.11 - Undergraduate Thesis
Organization:FDV - Faculty of Social Sciences
Place of publishing:Ljubljana
Publisher:[A. Trnavčević]
Year:2008
Number of pages:60 f.
PID:20.500.12556/RUL-10314 This link opens in a new window
UDC:373.5(043)
COBISS.SI-ID:27502685 This link opens in a new window
Publication date in RUL:11.07.2014
Views:7154
Downloads:226
Metadata:XML DC-XML DC-RDF
:
TRNAVČEVIĆ, Ana, 2008, Kakovost v edukativno-izobraževalnem procesu (audit kultura) : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : A. Trnavčević. [Accessed 27 March 2025]. Retrieved from: http://dk.fdv.uni-lj.si/diplomska/pdfs/Trnavcevic-Ana.PDF
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Pomen tumorskih matičnih celic in epitelno-mezenhimskega prehoda pri napredovanju nedrobnoceličnega raka pljuč
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Proučevanje izražanja gena za fosfatidiletanolamin-N-metiltransferazo v nedrobnoceličnem pljučnem rakavem tkivu
  4. Uporabnost imunohistokemičnega določanja mutacij receptorja za epidermalni rastni faktor pri raku pljuč
  5. Sladkorna bolezen in športna vadba
Similar works from other Slovenian collections:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Back